{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:45:31Z","timestamp":1794901531352,"version":"4.9.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004382","name":"Polska Akademia Nauk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004462","name":"National Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijbiomac.2024.136873","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:33:33Z","timestamp":1729701213000},"page":"136873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P2","title":["Exploring the binding mode of phenyl and vinyl boronic acids to human carbonic anhydrases"],"prefix":"10.1016","volume":"282","author":[{"given":"Davide","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Maria","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Winum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Alterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.136873_bb0005","article-title":"Structure, properties, and preparation of Boronic acid derivatives","author":"Hall","year":"2006","journal-title":"Overview of Their Reactions and Applications, in: Boronic Acids Prep. Appl. Org. Synth. Med."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0010","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1021\/ac500028v","article-title":"Reporter-free potentiometric sensing of boronic acids and their reactions by using quaternary ammonium salt-functionalized polymeric liquid membranes","volume":"86","author":"Wang","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25184323","article-title":"Boronic acids and their derivatives in medicinal chemistry: synthesis and biological applications","volume":"25","author":"Silva","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116748","article-title":"Boron-containing heterocycles as promising pharmacological agents","volume":"63","author":"Das","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0025","first-page":"1275","article-title":"Therapeutic potential of boron-containing compounds, future","volume":"1","author":"Baker","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0030","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.apsb.2021.01.010","article-title":"Recent developments in the medicinal chemistry of single boron atom-containing compounds","volume":"11","author":"Song","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108548","article-title":"Boron in cancer therapeutics: an overview","volume":"251","author":"Kulkarni","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/107327480301000502","article-title":"Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers","volume":"10","author":"Richardson","year":"2003","journal-title":"Cancer Control"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0045","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1080\/14656566.2018.1528229","article-title":"Ixazomib for the treatment of multiple myeloma","volume":"19","author":"Richardson","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112270","article-title":"Design and discovery of boronic acid drugs","volume":"195","author":"Plescia","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0055","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.clinthera.2007.08.005","article-title":"Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects","volume":"29","author":"O\u2019Farrell","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0060","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1080\/10428194.2016.1263842","article-title":"Phase I\/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma","volume":"58","author":"Vogl","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0065","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00726-021-03063-y","article-title":"Post-translational modifications in tumor-associated carbonic anhydrases","volume":"54","author":"Di Fiore","year":"2021","journal-title":"Amin. Acids"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0075","doi-asserted-by":"crossref","first-page":"12045","DOI":"10.3390\/ijms231912045","article-title":"a-CAs from Photosynthetic Organisms","volume":"23","author":"Langella","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0080","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0085","series-title":"Carbonic Anhydrases as Biocatalysts","year":"2015"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0090","doi-asserted-by":"crossref","first-page":"eabj0364","DOI":"10.1126\/sciadv.abj0364","article-title":"Genome-wide synthetic lethal screen unveils novel CAIX-NFS1\/xCT axis as a targetable vulnerability in hypoxic solid tumors","volume":"7","author":"Chafe","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0095","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol. Cancer Clin. Trials"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0100","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0105","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bmcl.2006.11.028","article-title":"Carbonic anhydrase inhibitors. Inhibition studies of the human secretory isoform VI with anions","volume":"17","author":"Nishimori","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0110","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.bmcl.2006.12.113","article-title":"Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions","volume":"17","author":"Innocenti","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0115","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bmcl.2008.12.082","article-title":"Carbonic anhydrase inhibitors: the membrane-associated isoform XV is highly inhibited by inorganic anions","volume":"19","author":"Innocenti","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0120","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.bmc.2009.03.058","article-title":"Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids","volume":"17","author":"Winum","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0125","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.bmcl.2009.03.147","article-title":"Carbonic anhydrase inhibitors. Inhibition of the fungal \u03b2-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids","volume":"19","author":"Innocenti","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106976","article-title":"Boron-containing carbonic anhydrases inhibitors","volume":"143","author":"Giovannuzzi","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0135","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.bmc.2016.07.035","article-title":"Bortezomib inhibits bacterial and fungal \u03b2-carbonic anhydrases","volume":"24","author":"Supuran","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0140","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1016\/j.bmc.2016.10.023","article-title":"Bortezomib inhibits mammalian carbonic anhydrases","volume":"25","author":"Supuran","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131268","article-title":"Identification, crystallization, and first X-ray structure analyses of phenyl boronic acid-based inhibitors of human carbonic anhydrase-II","volume":"267","author":"Rasheed","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0150","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1021\/bi100757c","article-title":"Crystal structure of a complex between the actinomadura R39 dd -peptidase and a peptidoglycan-mimetic boronate inhibitor: interpretation of a transition state analogue in terms of catalytic mechanism","volume":"49","author":"Dzhekieva","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsb742","article-title":"Crystal structure of a bacterial cocaine esterase","volume":"9","author":"Larsen","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126795","article-title":"Serendipitous discovery of aryl boronic acids as \u03b2-lactamase inhibitors","volume":"30","author":"Yang","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/pro.3100","article-title":"Exploring the potential of boronic acids as inhibitors of OXA-24\/40 \u03b2-lactamase","volume":"26","author":"Werner","year":"2017","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0170","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1126\/science.aaf8993","article-title":"The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design","volume":"(80-. ). 353","author":"Schrader","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0175","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1107\/S0907444906019949","article-title":"HKL-3000: the integration of data reduction and structure solution \u2013 from diffraction images to an initial model in minutes","volume":"62","author":"Minor","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0180","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/prot.340040406","article-title":"Refined structure of human carbonic anhydrase II at 2.0 a resolution","volume":"4","author":"Eriksson","year":"1988","journal-title":"Proteins"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0185","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1107\/S0108767390010224","article-title":"Improved methods for building protein models in electron density maps and the location of errors in these models","volume":"47","author":"Jones","year":"1991","journal-title":"Acta Crystallogr. Sect. A"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0200","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/381272a0","article-title":"Errors in protein structures [3]","volume":"381","author":"Hooft","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0205","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1039\/C6OB00803H","article-title":"The anticonvulsant sulfamide JNJ-26990990 and its S,S-dioxide analog strongly inhibit carbonic anhydrases: solution and X-ray crystallographic studies","volume":"14","author":"Di Fiore","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0210","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1039\/C4OB02648A","article-title":"X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor","volume":"13","author":"Alterio","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0215","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/14756366.2017.1405263","article-title":"Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor","volume":"33","author":"Alterio","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115783","article-title":"Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for \u03bc opioid receptor for safer and long-lasting analgesia","volume":"260","author":"Angeli","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0225","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/biology12020281","article-title":"A combined in silico and structural study opens new perspectives on aliphatic sulfonamides, a still poorly investigated class of CA inhibitors","volume":"12","author":"Langella","year":"2023","journal-title":"Biol"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0235","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/acsmedchemlett.0c00403","article-title":"Benzoxaboroles: new potent inhibitors of the carbonic anhydrases of the pathogenic bacterium vibrio cholerae","volume":"11","author":"Bonardi","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0240","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1021\/acsmedchemlett.7b00369","article-title":"Benzoxaboroles as efficient inhibitors of the \u03b2-carbonic anhydrases from pathogenic Fungi: activity and modeling study","volume":"8","author":"Nocentini","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0245","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/acsmedchemlett.9b00252","article-title":"Bis-benzoxaboroles: design, synthesis, and biological evaluation as carbonic anhydrase inhibitors","volume":"10","author":"Larcher","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0250","first-page":"1498","article-title":"Exploring benzoxaborole derivatives as carbonic anhydrase inhibitors: a structural and computational analysis reveals their conformational variability as a tool to increase enzyme selectivity","volume":"34","author":"Langella","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0255","doi-asserted-by":"crossref","first-page":"8118","DOI":"10.1021\/acs.jmedchem.3c00433","article-title":"6-Substituted Triazolyl Benzoxaboroles as Selective Carbonic Anhydrase Inhibitors: In Silico Design, Synthesis, and X-ray Crystallography","volume":"66","author":"Nocentini","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0260","doi-asserted-by":"crossref","first-page":"11983","DOI":"10.1039\/C6CC06399C","article-title":"Benzoxaborole as a new chemotype for carbonic anhydrase inhibition","volume":"52","author":"Alterio","year":"2016","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0265","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/acschembio.9b00895","article-title":"Conformational changes in alkyl chains determine the thermodynamic and kinetic binding profiles of carbonic anhydrase inhibitors","volume":"15","author":"Gl\u00f6ckner","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2024.136873_bb0270","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm9900523","article-title":"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J. Med. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024076827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024076827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T09:24:49Z","timestamp":1733131489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024076827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":53,"alternative-id":["S0141813024076827"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136873","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the binding mode of phenyl and vinyl boronic acids to human carbonic anhydrases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"136873"}}